Phase
Condition
Neuropathy
Nerve Injury
Amyloidosis
Treatment
N/AClinical Study ID
Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Documentation that the patient was exposed to patisiran-LNP at any point startingfrom 12 weeks before LMP or at any point during pregnancy
Exclusion
Exclusion Criteria:
- There are no exclusion criteria for participation in this program.
Study Design
Connect with a study center
Clinical Trial Site
Nantes,
FranceSite Not Available
Clinical Trial Site
Nantes 2990969,
FranceActive - Recruiting
Clinical Trial Site
Münster,
GermanySite Not Available
Clinical Trial Site
Münster 2867543,
GermanyActive - Recruiting
Clinical Trial Site
Pavia,
ItalySite Not Available
Clinical Trial Site
Pavia 3171366,
ItalyActive - Recruiting
Clinical Trial Site
Groningen,
NetherlandsSite Not Available
Clinical Trial Site
Groningen 2755251,
NetherlandsActive - Recruiting
Clinical Trial Site
Lisboa,
PortugalSite Not Available
Clinical Trial Site
Lisbon 2267057,
PortugalActive - Recruiting
Clinical Trial Site
Madrid,
SpainSite Not Available
Clinical Trial Site
Madrid 3117735,
SpainActive - Recruiting
Clinical Trial Site
Iowa City, Iowa 52242
United StatesSite Not Available
Clinical Trial Site
Iowa City 4862034, Iowa 4862182 52242
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.